3-morpholinosydnonimine (SIN-1)-induced oxidative stress leads to necrosis in hypertrophic chondrocytes in vitro

Biomed Pharmacother. 2018 Oct:106:1696-1704. doi: 10.1016/j.biopha.2018.07.128. Epub 2018 Jul 30.

Abstract

Chondrocyte is targeted for disruption in Osteoarthritis (OA) and Kashin-Beck Disease (KBD), and chondrocyte death in cartilage may contribute to the progression of OA and KBD. Oxidative stress leads to increased risk for OA. Previous work in our laboratory implicates oxidative stress as a potential mediator in children with KBD. While these studies suggest a role for oxidative stress in the modulation of OA and KBD, the direct effects of reactive oxygen species/reactive nitrogen species (ROS/RNS) on the stability of this domain remain unclear. Here, we demonstrate that oxidative stress, as induced through treatment with 3-morpholinosydnonimine (SIN-1), a spontaneous ROS/RNS generator, decreased the cell viability in hypertrophic chondrocytes in a dose- and time- dependent manner. SIN-1 induced necrosis in hypertrophic chondrocytes, whereas triggered apoptosis in non-hypertrophic cells of non-differentiated ATDC5 cells and C28/I2 cells. Ultrastructural analysis of hypertrophic chondrocyte treated with SIN-1 revealed morphological changes, such as plasma membrane breakdown, generalized swelling of the cytoplasm and organelles, even to disappearance. Moreover, SIN-1 induced chondronecrosis in the deep zone of engineered cartilage tissue, such as cell-free vacancy and "red ghost" cells. Overall, we demonstrate for the first time that oxidative stress, as induced through exogenous ROS/RNS, leads to necrosis in hypertrophic chondrocytes. Oxidative stress-mediated necrotic cell death contributes to chondronecrosis in the deep zone of cartilage in both OA and KBD.

Keywords: Apoptosis; Hypertrophic chondrocytes; Necrosis; Oxidative stress.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cartilage / drug effects*
  • Cartilage / metabolism
  • Cartilage / pathology
  • Case-Control Studies
  • Cell Line
  • Cell Survival / drug effects
  • Chondrocytes / drug effects*
  • Chondrocytes / metabolism
  • Chondrocytes / ultrastructure
  • Dose-Response Relationship, Drug
  • Humans
  • Hypertrophy
  • Kashin-Beck Disease / metabolism
  • Kashin-Beck Disease / pathology*
  • Mice
  • Molsidomine / analogs & derivatives*
  • Molsidomine / pharmacology
  • Necrosis
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology*
  • Oxidants / pharmacology*
  • Oxidative Stress / drug effects*
  • Reactive Nitrogen Species / metabolism
  • Reactive Oxygen Species / metabolism
  • Time Factors
  • Tissue Engineering

Substances

  • Oxidants
  • Reactive Nitrogen Species
  • Reactive Oxygen Species
  • linsidomine
  • Molsidomine